Cargando…

Radiological and Functional Pulmonary Evolution in Post-COVID-19 Patients: An Observational Study

COVID-19 has generated a scenario for global health with multiple systemic impairments. This retrospective study evaluated the clinical, radiological, and pulmonary functional evolution in 302 post-COVID-19 patients. Regarding post-COVID-19 pulmonary symptoms, dry cough, dyspnea, and chest pain were...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavallari Strozze Catharin, Virgínia Maria, Zutin, Tereza Laís Menegucci, Guiguer, Elen Landgraf, Cressoni Araújo, Adriano, Fornari Laurindo, Lucas, Chagas, Eduardo F. Baisi, Gasparotti Zorzetto, Cássia Fernanda, Bueno, Patrícia C. dos Santos, dos Santos Bueno, Manoela, Cervelim Nunes, Yandra, Cavallari Strozze Catharin, Vitor, Gonzaga, Heron Fernando, Barbalho, Sandra Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528437/
https://www.ncbi.nlm.nih.gov/pubmed/37754309
http://dx.doi.org/10.3390/diseases11030113
Descripción
Sumario:COVID-19 has generated a scenario for global health with multiple systemic impairments. This retrospective study evaluated the clinical, radiological, and pulmonary functional evolution in 302 post-COVID-19 patients. Regarding post-COVID-19 pulmonary symptoms, dry cough, dyspnea, and chest pain were the most frequent. Of the associated comorbidities, asthma was more frequent (23.5%). Chest tomography (CT) initially showed a mean pulmonary involvement of 69.7%, and evaluation in the subsequent months showed improvement in the evolutionary image. With less than six months post-pathology, there was a commitment of 37.7% from six to twelve months it was 20%, and after 12 months it was 9.9%. As for most of the sample, 50.3% of the patients presented CT normalization less than six months after infection, 23% were normalized between six and twelve months, and 5.2% presented with normalized images after twelve months, with one remaining. A percentage of 17.3% maintained post-COVID-19 pulmonary residual sequelae. Regarding spirometry, less than six months after pathology, 59.3% of the patients presented regular exam results, 12.3% had their function normalized within six to twelve months, and 6.3% had normal exam results twelve months after their post-pathology evaluation. Only 3.6% of the patients still showed some alteration during this period.